Abstract
Folate antagonists are classified as important and valuable therapeutic agents against infection, neoplastic, and inflammatory diseases. Dihydrofolate reductase (DHFR) is a biological target of two well-defined folate antagonists, classical and non-classical inhibitors. DHFR catalyzes the reduction of 7,8-dihydrofolate to 5,6,7,8-tetrahydrofolate benefits of NADPH as a cofactor. With the point to recognize new chemicals to be utilized for further structure-based drug design, a collection of 67753 molecules including chemicals and natural products have been screened through the docking method from the Zinc Database. The high ranked compound with regard to methotrexate (MTX), resulted to be three compounds comprises of ZINC29236925, ZINC31169388, and ZINC01629864, which further investigated by molecular dynamics (MD) simulation, Poisson–Boltzmann surface area method (MM-PBSA) and QMMM calculations. PCA analysis revealed that upon inhibitor binding, the DHFR folding is changed. Our QMMM data suggested that a structure with ZINC ID of ZINC31169388 has a stronger interaction with DHFR active site and could be a favorable candidacy for biological assessment and additional advanced improvement. Furthermore, ADMET prediction illustrated that all physicochemical factors of ZINC31169388 are within the satisfactory span described for human treatment.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13721-020-00244-9/MediaObjects/13721_2020_244_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13721-020-00244-9/MediaObjects/13721_2020_244_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13721-020-00244-9/MediaObjects/13721_2020_244_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13721-020-00244-9/MediaObjects/13721_2020_244_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13721-020-00244-9/MediaObjects/13721_2020_244_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13721-020-00244-9/MediaObjects/13721_2020_244_Fig6_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13721-020-00244-9/MediaObjects/13721_2020_244_Fig7_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13721-020-00244-9/MediaObjects/13721_2020_244_Fig8_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13721-020-00244-9/MediaObjects/13721_2020_244_Fig9_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13721-020-00244-9/MediaObjects/13721_2020_244_Fig10_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13721-020-00244-9/MediaObjects/13721_2020_244_Fig11_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13721-020-00244-9/MediaObjects/13721_2020_244_Fig12_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13721-020-00244-9/MediaObjects/13721_2020_244_Fig13_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13721-020-00244-9/MediaObjects/13721_2020_244_Fig14a_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13721-020-00244-9/MediaObjects/13721_2020_244_Fig14b_HTML.png)
Similar content being viewed by others
References
Ajay Bemis GW, Murcko MA (1999) Designing libraries with CNS activity. J Med Chem 42:4942–4951
Arai M, Kondrashkina E, Kayatekin C, Matthews CR, Iwakura M, Bilsel O (2007) Microsecond hydrophobic collapse in the folding of Escherichia coli dihydrofolate reductase, an α/β-type protein. J Mol Biol 368:219–229
Arooj M, Thangapandian S, John S, Hwang S, Park JK, Lee KW (2011) 3D QSAR pharmacophore modeling, in silico screening, and density functional theory (DFT) approaches for identification of human chymase inhibitors. Int J Mol Sci 12:9236–9264
Arora K, Brooks Iii CL (2009) Functionally important conformations of the Met20 loop in dihydrofolate reductase are populated by rapid thermal fluctuations. J Am Chem Soc 131:5642–5647
Banerjee P, Eckert AO, Schrey AK, Preissner R (2018) ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 46:W257–W263
Bas DC, Rogers DM, Jensen JH (2008) Very fast prediction and rationalization of pKa values for protein–ligand complexes. Proteins Struct Funct Bioinform 73:765–783
Bebrone C, Lassaux P, Vercheval L, Sohier J-S, Jehaes A, Sauvage E et al (2010) Current challenges in antimicrobial chemotherapy. Drugs 70:651–679
Becke AD (1993) Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys 98:5648–5652
Bolin JT, Filman DJ, Matthews DA, Hamlin RC, Kraut J (1982) Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. I. General features and binding of methotrexate. J Biol Chem 257:13650–13662
Bussi G, Donadio D, Parrinello M (2007) Canonical sampling through velocity rescaling. J Chem Phys 126:014101
Calvert H (2003) Pemetrexed (Alimta): a promising new agent for the treatment of breast cancer. Semin Oncol 30(2 Suppl 3):2–5. https://doi.org/10.1053/sonc.2003.37267
Carlson HA, Jorgensen WL (1995) An extended linear response method for determining free energies of hydration. J Phys Chem 99:10667–10673
Cavalli A, Poluzzi E, De Ponti F, Recanatini M (2002) Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K+ channel blockers. J Med Chem 45:3844–3853
Chen M-J, Shimada T, Moulton AD, Cline A, Humphries RK, Maizel J et al (1984) The functional human dihydrofolate reductase gene. J Biol Chem 259:3933–3943
Cheng T, Li Q, Zhou Z, Wang Y, Bryant SH (2012) Structure-based virtual screening for drug discovery: a problem-centric review. AAPS J 14:133–141
Chu E, Takimoto CH, Voeller D, Grem JL, Allegra CJ (1993) Specific binding of human dihydrofolate reductase protein to dihydrofolate reductase messenger RNA in vitro. Biochemistry 32:4756–4760
Cody V, Luft J, Ciszak E, Kalman T, Freisheim J (1992) Crystal structure determination at 2.3 A of recombinant human dihydrofolate reductase ternary complex with NADPH and methotrexate-gamma-tetrazole. Anti Cancer Drug Des 7:483–491
Cody V, Galitsky N, Luft JR, Pangborn W, Rosowsky A, Blakley RL (1997) Comparison of two independent crystal structures of human dihydrofolate reductase ternary complexes reduced with nicotinamide adenine dinucleotide phosphate and the very tight-binding inhibitor PT523. Biochemistry 36:13897–13903
Cody V, Luft JR, Pangborn W (2005) Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH. Acta Crystallogr D Biol Crystallogr 61:147–155
Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an N· log (N) method for Ewald sums in large systems. J Chem Phys 98:10089–10092
Elslager EF, Johnson JL, Werbel LM (1983) Folate antagonists. 20. Synthesis and antitumor and antimalarial properties of trimetrexate and related 6-[(phenylamino) methyl]-2,4-quinazolinediamines. J Med Chem 26:1753–1760
Ercikan-Abali EA, Banerjee D, Waltham MC, Skacel N, Scotto KW, Bertino JR (1997) Dihydrofolate reductase protein inhibits its own translation by binding to dihydrofolate reductase mRNA sequences within the coding region. Biochemistry 36:12317–12322
Essmann U, Perera L, Berkowitz ML (1995) The origin of the hydration interaction of lipid bilayers from MD simulation of dipalmitoylphosphatidylcholine membranes in gel and liquid crystalline phases. Langmuir 11:4519–4531
Felson DT, Chernoff M, Anderson J, Weinblatt M, Furst D, Schmid F et al (1995) The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis. J Rheumatol 22:218–223
Gasteiger J, Marsili M (1980) Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges. Tetrahedron 36:3219–3228
Genheden S, Ryde U (2015) The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449–461
Grivsky EM, Lee S, Sigel CW, Duch DS, Nichol CA (1980) Synthesis and antitumor activity of 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine. J Med Chem 23:327–329
Günther S, Senger C, Michalsky E, Goede A, Preissner R (2006) Representation of target-bound drugs by computed conformers: implications for conformational libraries. BMC Bioinform 7:1
Herfarth HH, Long MD, Isaacs KL (2013) Methotrexate: underused and ignored? Dig Dis 30:112–118
Hess B, Bekker H, Berendsen HJ, Fraaije JG (1997) LINCS: a linear constraint solver for molecular simulations. J Comput Chem 18:1463–1472
Hileman B (2006) Accounting for R&D-Many doubt the $800 million pharmaceutical price tag. Chem Eng News 84:50
Hou T, Wang J, Li Y, Wang W (2011) Assessing the performance of the MM/PBSA and MM/GBSA methods: II. The accuracy of ranking poses generated from docking. J Comput Chem 32:866–877
Hsu M-C, Chen C-C (2015) Low-dose methotrexate-induced ulcerated psoriatic plaques: a rare case. JAAD Case Rep 1:264–266
Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:33–38
Irwin JJ, Shoichet BK (2005) ZINC-a free database of commercially available compounds for virtual screening. J Chem Inf Model 45:177–182
Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA (1983) The pharmacology and clinical use of methotrexate. N Engl J Med 309:1094–1104
Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926–935
Jorgensen WL, Maxwell DS, Tirado-Rives J (1996) Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 118:11225–11236
Karami M, Jalali C, Mirzaie S (2017) Combined virtual screening, MMPBSA, molecular docking and dynamics studies against deadly anthrax: an in silico effort to inhibit Bacillus anthracis nucleoside hydrolase. J Theor Biol 420:180–189
Kelder J, Grootenhuis PD, Bayada DM, Delbressine LP, Ploemen J-P (1999) Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm Res 16:1514–1519
Klon AE, Héroux A, Ross LJ, Pathak V, Johnson CA, Piper JR et al (2002) Atomic structures of human dihydrofolate reductase complexed with NADPH and two lipophilic antifolates at 1.09 Å and 1.05 Å resolution. J Mol Biol 320:677–693
Kollman P (1993) Free energy calculations: applications to chemical and biochemical phenomena. Chem Rev 93:2395–2417
Kollman PA, Massova I, Reyes C, Kuhn B, Huo S, Chong L et al (2000) Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res 33:889–897
Kovalevskaya NV, Smurnyy YD, Polshakov VI, Birdsall B, Bradbury AF, Frenkiel T et al (2005) Solution structure of human dihydrofolate reductase in its complex with trimethoprim and NADPH. J Biomol NMR 33:69–72
Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ, Wilske KR (1989) Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 110:353–356
Kumar K, Anbarasu A, Ramaiah S (2014) Molecular docking and molecular dynamics studies on β-lactamases and penicillin binding proteins. Mol BioSyst 10:891–900
Kumari R, Kumar R, Lynn A (2014) g_mmpbsa: a GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model 54:1951–1962
Lee C, Yang W, Parr RG (1988) Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B 37:785
Luco JM (1999) Prediction of the brain–blood distribution of a large set of drugs from structurally derived descriptors using partial least-squares (PLS) modeling. J Chem Inf Comput Sci 39:396–404
McElheny D, Schnell JR, Lansing JC, Dyson HJ, Wright PE (2005) Defining the role of active-site loop fluctuations in dihydrofolate reductase catalysis. Proc Natl Acad Sci USA 102:5032–5037
Mirzaie S, Rafii F, Yasunaga K, Yoshunaga K, Sepehrizadeh Z, Kanno S et al (2012) Prediction of the mode of interaction between monoterpenes and the nitroreductase from Enterobacter cloacae by docking simulation. Comput Biol Med 42:414–421
Mirzaie S, Najafi K, Hakhamaneshi MS, Shahverdi AR, Fathi F (2015) Investigation for antimicrobial resistance-modulating activity of diethyl malate and 1-methyl malate against beta-lactamase class A from Bacillus licheniformis by molecular dynamics, in vitro and in vivo studies. J Biomol Struct Dyn 33:1016–1026
Mollica A, Mirzaie S, Costante R, Carradori S, Macedonio G, Stefanucci A et al (2015) Exploring the biological consequences of conformational changes in aspartame models containing constrained analogues of phenylalanine. J Enzym Inhib Med Chem 31(6):953–963. https://doi.org/10.3109/14756366.2015.1076811
Mullarkey M, Andrade W, Blumenstein B, Bailey G (1988) Methotrexate in the treatment of corticosteroid-dependent asthma: a double-blind crossover study with follow-up. J Allergy Clin Immunol 81:182
Parrinello M, Rahman A (1981) Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys 52:7182–7190
Potts SJ, Edwards DJ, Hoffman R (2005) Challenges of target/compound data integration from disease to chemistry: a case study of dihydrofolate reductase inhibitors. Curr Drug Discov Technol 2:75–87
Söderhjelm P, Kongsted J, Ryde U (2010) Ligand affinities estimated by quantum chemical calculations. J Chem Theory Comput 6:1726–1737
Rajagopalan PT, Zhang Z, McCourt L, Dwyer M, Benkovic SJ, Hammes GG (2002) Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics. Proc Natl Acad Sci USA 99:13481–13486
Rajamanikandan S, Jeyakanthan J, Srinivasan P (2017) Discovery of potent inhibitors targeting Vibrio harveyi LuxR through shape and e-pharmacophore based virtual screening and its biological evaluation. Microb Pathog 103:40–56
Rodrigues T, Reker D, Schneider P, Schneider G (2016) Counting on natural products for drug design. Nat Chem 8:531–541
Sawaya MR, Kraut J (1997) Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: crystallographic evidence. Biochemistry 36:586–603
Searles G, McKendry R (1987) Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature. J Rheumatol 14:1164–1171
Sompornpisut P, Wijitkosoom A, Parasuk V, Sirawaraporn W (2003) Molecular dynamics simulation of the human apo-dihydrofolate reductase: an investigation of an unstable enzyme. Mol Simul 29:111–121
Stein RB, Hanauer SB (2000) Comparative tolerability of treatments for inflammatory bowel disease. Drug Saf 23:429–448
Sun H, Li Y, Shen M, Tian S, Xu L, Pan P et al (2014) Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring. Phys Chem Chem Phys 16:22035–22045
Teramoto R, Fukunishi H (2007) Supervised consensus scoring for docking and virtual screening. J Chem Inf Model 47:526–534
Tosso RD, Andujar SA, Gutierrez L, Angelina E, Rodríguez R, Nogueras M et al (2013) Molecular modeling study of dihydrofolate reductase inhibitors. Molecular dynamics simulations, quantum mechanical calculations, and experimental corroboration. J Chem Inf Model 53:2018–2032
Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461
Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ (2005) GROMACS: fast, flexible, and free. J Comput Chem 26:1701–1718
Wang J, Wang W, Kollman PA, Case DA (2006a) Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model 25:247–260
Wang J, Hou T, Xu X (2006b) Recent advances in free energy calculations with a combination of molecular mechanics and continuum models. Curr Comput Aided Drug Des 2:287–306
Weinblatt M (2003) Rheumatoid arthritis in 2003: where are we now with treatment? Ann Rheum Dis 62:ii94–ii96
Weinstein GD, Goldfaden G, Frost P (1971) Methotrexate: mechanism of action on DNA synthesis in psoriasis. Arch Dermatol 104:236–243
Yazdanian M, Glynn SL, Wright JL, Hawi A (1998) Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds. Pharm Res 15:1490–1494
Zhan D, Yu L, ** H, Guan S, Han W (2014) Molecular modeling and MM-PBSA free energy analysis of endo-1,4-β-xylanase from Ruminococcus albus 8. Int J Mol Sci 15:17284–17303
Zhang D, Lazim R (2017) Application of conventional molecular dynamics simulation in evaluating the stability of apomyoglobin in urea solution. Sci Rep 7:44651
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Koushki, E.H., Abolghasemi, S., Mollica, A. et al. Structure-based virtual screening, molecular docking and dynamics studies of natural product and classical inhibitors against human dihydrofolate reductase. Netw Model Anal Health Inform Bioinforma 9, 49 (2020). https://doi.org/10.1007/s13721-020-00244-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13721-020-00244-9